Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€13.30

€13.30

-3.620%
-0.5
-3.620%
-
 
06.02.26 / Frankfurt WKN: A1J2YC / Name: ALS / Stock / Professional & Commercial Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

ALS Ltd Stock

Heavy losses for ALS Ltd today as the stock fell by -€0.500 (-3.620%).

Pros and Cons of ALS Ltd in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of ALS Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
ALS Ltd -3.620% -3.623% 3.101% 31.683% 7.258% 69.427% 90.000%
Emcor Group Inc. 2.850% 8.273% 16.455% 58.140% 24.547% 377.971% -
Robert Half International 0.000% -20.149% -14.400% -62.783% -9.322% -73.082% -64.918%
KBR Inc. 2.350% -6.077% -10.526% -33.981% -0.585% - -

News

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
  • This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages
RE-Transmission: Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project
RE-Transmission: Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project

Vancouver, BC – January 30, 2026 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | FSE: SL51) is pleased to announce that the Company plans to undertake

Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project: https://www.irw-press.at/prcom/images/messages/2026/82794/UUU_013026_ENPRcom.001.jpeg
Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project

Vancouver, BC – January 30, 2026 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | FSE: SL51) is pleased to announce that the Company plans to undertake